Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Warrant Expiry
and
Block Admission Cancellation
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that all warrants issued alongside its capital raise announced 6 May 2022 have now expired ("Warrants").
Further to the above the Company has made application to AIM to cancel the Company's Block Admission, which was originally established to facilitate the issuance of ordinary shares following receipt of any exercise of the Warrants (the "Cancellation"). The Cancellation will become effective Monday 13 November, as such no further interim returns will be published in relation to the Company's Block Admission. The Balance of ordinary shares under the Block Admission not issued/allotted at the time of Cancellation is 90,000,000.
Contacts:
| Cambridge Nutritional Sciences plc | ||||
| Jag Grewal, Chief Executive Officer | via Walbrook PR | |||
| | | |||
| | | |||
| Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |||
| Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) | | |||
| Nigel Birks / Harriet Ward (ECM) | | |||
| | | |||
| | | |||
| Walbrook PR Limited | Tel: 020 7933 8780 or CNS@walbrookpr.com | |||
| Paul McManus / Charlotte Edgar | Mob: 07980 541 893 / 07884 664 686 | |||
| Sam Allen | Mob: 07502 558 258 | |||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.